A case of metastatic renal cell carcinoma showing complete remission after cytoreductive nephrectomy followed by temsirolimus

被引:0
|
作者
Naotaka Nishiyama
Naoya Masumori
机构
[1] Sapporo Medical University School of Medicine,Department of Urology
关键词
Poor-risk renal cell carcinoma; Temsirolimus; Complete remission;
D O I
10.1007/s13691-016-0261-y
中图分类号
学科分类号
摘要
Here, we present a case report of a patient with poor-risk advanced renal cell carcinoma who had a complete remission after cytoreductive nephrectomy followed by temsirolimus. A 67-year-old woman was diagnosed with advanced renal cell carcinoma, stage pT3aN2M1 in April 2013. In the Memorial Sloan-Kettering Cancer Center criteria, she had three prognostic factors and was classified into the poor-risk category. After 23 weeks of treatment with temsirolimus, complete remission was achieved. Temsirolimus treatment was discontinued after 23 weeks because of grade 3 toxicity noninfectious pneumonitis. Five months after beginning steroid treatment without temsirolimus, a CT scan showed no new metastatic lesion or progression of disease. This was a very rare case with achievement of a complete remission after cytoreductive nephrectomy followed by temsirolimus.
引用
收藏
页码:4 / 7
页数:3
相关论文
共 50 条
  • [21] Partial cytoreductive nephrectomy versus cytoreductive nephrectomy in metastatic renal cell carcinoma.
    Vitruk, Iurly
    Stakhovskyi, Oleksandr
    Voylenko, Oleg
    Kotov, Volodymyr
    Pikul, Maxim
    Stakhovsky, Eduard
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [22] SARCOPENIA AS A PREDICTOR OF SURVIVAL AFTER CYTOREDUCTIVE NEPHRECTOMY FOR METASTATIC RENAL CELL CARCINOMA
    Sharma, Pranav
    Zargar-Shoshtari, Kamran
    Caracciolo, Jamie
    Fishman, Mayer
    Poch, Michael
    Pow-Sang, Julio
    Sexton, Wade
    Spiess, Philippe
    JOURNAL OF UROLOGY, 2015, 193 (04): : E733 - E733
  • [23] REGRESSION OF METASTATIC RENAL-CELL CARCINOMA AFTER CYTOREDUCTIVE NEPHRECTOMY - COMMENT
    NOVICK, AC
    JOURNAL OF UROLOGY, 1993, 150 (02): : 466 - 466
  • [24] Refining the Use of Cytoreductive Nephrectomy in Metastatic Renal Cell Carcinoma
    La Rochelle, Jeffrey
    Wood, Christopher
    Bex, Axel
    SEMINARS IN ONCOLOGY, 2013, 40 (04) : 429 - 435
  • [25] The role of cytoreductive nephrectomy in metastatic renal cell carcinoma.
    Alnimer, Yanal Mufeed
    Qasrawi, Ayman
    Katato, Khalil
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [26] The current role of cytoreductive nephrectomy for metastatic renal cell carcinoma
    Umbreit, Eric C.
    McIntosh, Andrew G.
    Suk-Ouichai, Chalairat
    Karam, Jose A.
    Wood, Christopher G.
    INDIAN JOURNAL OF UROLOGY, 2021, 37 (01) : 13 - 16
  • [27] Commentary on the role of cytoreductive nephrectomy in metastatic renal cell carcinoma
    Schulz, Gerald
    AKTUELLE UROLOGIE, 2023, 54 (03) : 180 - 181
  • [28] The evolving role of cytoreductive nephrectomy in metastatic renal cell carcinoma
    Graham, Jeffrey
    Bhindi, Bimal
    Heng, Daniel Y. C.
    CURRENT OPINION IN UROLOGY, 2019, 29 (05) : 507 - 512
  • [29] Current role of cytoreductive nephrectomy in metastatic renal cell carcinoma
    Van Praet, Charles
    Slots, Charlotte
    Vasdev, Nikhil
    Roney, Sylvie
    Fonteyne, Valerie
    Andras, Lulia
    Albersen, Maarten
    De Meerleer, Gert
    Bex, Axel
    Decaestecker, Karel
    TURKISH JOURNAL OF UROLOGY, 2021, 47 : S79 - S84
  • [30] The Evolving Landscape of Cytoreductive Nephrectomy in Metastatic Renal Cell Carcinoma
    Studentova, Hana
    Spisarova, Martina
    Kopova, Andrea
    Zemankova, Anezka
    Melichar, Bohuslav
    Student, Vladimir
    CANCERS, 2023, 15 (15)